RankAlpha logo
Back to Rankings

RANI

Rani TherapeuticsB
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
Above peers
vs peer average
RANI vs peer average
75/100
RANI vs. peer average (B vs. D)
Grade spread
A 1 · B 4 · F 6
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

MXCT is the first available peer comparator.

Healthcare tools/biotech-adjacent name of similar market cap; best used as a rough sentiment and capital-markets comparator, not a direct pipeline peer.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerMXCTMaxCyte
RANI
Rani Therapeutics
MXCT
MaxCyte
Grade
B
F
Momentum
85
19
Value
41
41
Sentiment
55
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs MXCT

RANI / MXCT
Grade Position
Above peers
RANI vs. peer average (B vs. D)
75/100
Momentum
85
RANI
Value
41
RANI
Sentiment
55
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs RANI
1
MXCT
MXCT
F
20/100
+3
2
SRZN
SRZN
B
80/100
Even
3
VTVT
VTVT
B
80/100
Even
4
CBUS
Cibus Inc Class A Common
B
80/100
Even
5
PYXS
Pyxis Oncology Inc Common
F
20/100
+3
MXCT is the first peer returned for this comparison set.